APA (7th ed.) Citation

ZX, Z., L, Y., JT, C., Y, Z., SX, D., & SJ, L. (2026). TK1 in gastric cancer: Helicobacter pylori-driven oncogenesis biomarker, utility, and emerging targeted therapies. Frontiers in oncology, 16, 1641930. https://doi.org/10.3389/fonc.2026.1641930

Chicago Style (17th ed.) Citation

ZX, Zheng, Yang L, Chen JT, Zeng Y, Dai SX, and Liu SJ. "TK1 in Gastric Cancer: Helicobacter Pylori-driven Oncogenesis Biomarker, Utility, and Emerging Targeted Therapies." Frontiers in Oncology 16 (2026): 1641930. https://doi.org/10.3389/fonc.2026.1641930.

MLA (9th ed.) Citation

ZX, Zheng, et al. "TK1 in Gastric Cancer: Helicobacter Pylori-driven Oncogenesis Biomarker, Utility, and Emerging Targeted Therapies." Frontiers in Oncology, vol. 16, 2026, p. 1641930, https://doi.org/10.3389/fonc.2026.1641930.